{"transactions":[{"id":2672595,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138385,"kind":"person","name":"Griggs Jonathan","position":1,"cik":"0001490828","reported_name":"Griggs Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T21:19:10.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":1000,"price":3.22,"value":3220.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 17, 2022."}],"balance_after":14803,"source":{"system":"sec-edgar","filing":"0001209191-21-039933","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121039933/doc4.xml","form_type":"4"}},{"id":3174611,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138385,"kind":"person","name":"Griggs Jonathan","position":1,"cik":"0001490828","reported_name":"Griggs Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-17T21:20:58.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":1000,"price":3.56,"value":3560.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 23, 2021."}],"balance_after":13803,"source":{"system":"sec-edgar","filing":"0001209191-20-024889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919120024889/doc4.xml","form_type":"4"}},{"id":3581988,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138385,"kind":"person","name":"Griggs Jonathan","position":1,"cik":"0001490828","reported_name":"Griggs Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T21:13:19.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":1000,"price":5.98,"value":5980.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 18, 2020."}],"balance_after":12803,"source":{"system":"sec-edgar","filing":"0001209191-19-021027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119021027/doc4.xml","form_type":"4"}},{"id":3984183,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138385,"kind":"person","name":"Griggs Jonathan","position":1,"cik":"0001490828","reported_name":"Griggs Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-23T21:43:39.000Z","date":"2018-03-23","kind":"grant","acquired":true,"shares":1000,"price":6.7,"value":6700.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 20, 2019."}],"balance_after":11803,"source":{"system":"sec-edgar","filing":"0001209191-18-021474","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118021474/doc4.xml","form_type":"4"}},{"id":4296520,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138385,"kind":"person","name":"Griggs Jonathan","position":1,"cik":"0001490828","reported_name":"Griggs Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-02T21:22:26.000Z","date":"2017-05-31","kind":"sale","acquired":false,"shares":8000,"price":6.97,"value":55760.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold to Cumberland Pharmaceuticals Inc."}],"balance_after":10803,"source":{"system":"sec-edgar","filing":"0001209191-17-037366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117037366/doc4.xml","form_type":"4"}},{"id":4356558,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138385,"kind":"person","name":"Griggs Jonathan","position":1,"cik":"0001490828","reported_name":"Griggs Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-07T21:03:36.000Z","date":"2017-04-07","kind":"grant","acquired":true,"shares":1000,"price":6.45,"value":6450.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 17, 2018."}],"balance_after":18803,"source":{"system":"sec-edgar","filing":"0001209191-17-026320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117026320/doc4.xml","form_type":"4"}}]}